{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:26:35Z","timestamp":1787109995532,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":3823,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.anpedi.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T06:18:17Z","timestamp":1434262697000},"page":"177.e1-177.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recomendaciones para el uso de metotrexato en pacientes con artritis idiop\u00e1tica juvenil"],"prefix":"10.1016","volume":"84","author":[{"given":"I.","family":"Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"L\u00f3pez Robledillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de Inocencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Gamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Rua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bustabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"D\u00edaz Cordov\u00e9s-Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2015.05.005_bib0205","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clim.2011.10.003","article-title":"Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis","volume":"142","author":"Dueckers","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/11588140-000000000-00000","article-title":"Juvenile idiopathic arthritis: New insights into classification, measures of outcome, and pharmacotherapy","volume":"13","author":"Beresford","year":"2011","journal-title":"Paediatric Drugs"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0220","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer's handbook. Edinburgh: SIGN; 2014. (SIGN publication no. 50). [October 2014]. Available from URL: http:\/\/www.sign.ac.uk"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0225","series-title":"Evidence-based Pediatrics","author":"Feldman","year":"2000"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0230","unstructured":"Oxford Centre for Evidence-Based Medicine. Levels of evidence. 2009 [consultado 9 Oct 2014]. Disponible en: http:\/\/www.cebm.net\/oxford-centre-evidence-based-medicinelevels-evidence-march-2009\/"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00296-004-0537-y","article-title":"Evidence-based use of methotrexate in children with rheumatic diseases: A consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria","volume":"25","author":"Niehues","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0245","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: A systematic review of the literature","volume":"27","author":"Visser","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0250","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.2007.075895","article-title":"Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis","volume":"67","author":"Cespedes-Cruz","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0260","first-page":"435","article-title":"[Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate]","volume":"41","author":"Gao","year":"2003","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0265","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0270","first-page":"218","article-title":"The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Rheumatoid Arthritis Clinical Trial Archive Group","volume":"22","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0275","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","article-title":"Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: Interdisciplinary panel consensus","volume":"35","author":"Bou","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0280","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0285","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jpeds.2013.03.047","article-title":"Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis","volume":"163","author":"Papadopoulou","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0290","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","article-title":"Current evidence of methotrexate efficacy in childhood chronic uveitis: A systematic review and meta-analysis approach","volume":"52","author":"Simonini","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0295","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1200\/JCO.1988.6.12.1882","article-title":"Pharmacokinetics of subcutaneous methotrexate","volume":"6","author":"Balis","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0300","first-page":"2342","article-title":"Pharmacokinetics of oral methotrexate in children","volume":"43","author":"Balis","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0305","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/art.1780350603","article-title":"Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis","volume":"35","author":"Oguey","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1529-0131(199803)41:3<381::AID-ART2>3.0.CO;2-3","article-title":"The use of methotrexate in childhood rheumatic diseases","volume":"41","author":"Wallace","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0315","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1002\/art.30475","article-title":"Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO study","volume":"63","author":"Hasija","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0320","unstructured":"Ficha t\u00e9cnica de Metoject. [consultado 3 Abr 2013]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=71109&formato=pdf&formulario=FICHAS"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0325","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0330","first-page":"2501","article-title":"Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis","volume":"31","author":"Ortiz-Alvarez","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0335","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3899\/jrheum.090482","article-title":"Monitoring methotrexate toxicity in juvenile idiopathic arthritis","volume":"36","author":"Kocharla","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0340","first-page":"2442","article-title":"Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy","volume":"29","author":"Lahdenne","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0345","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(99)70371-9","article-title":"The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis","volume":"134","author":"Hashkes","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0350","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/anr.1780320604","article-title":"Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis","volume":"32","author":"Wallace","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0355","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.24087","article-title":"Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis","volume":"61","author":"Albers","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0360","first-page":"179","article-title":"The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate","volume":"31","author":"Alsufyani","year":"2004","journal-title":"J Rheumatol"},{"issue":"Suppl 10","key":"10.1016\/j.anpedi.2015.05.005_bib0365","first-page":"2598","article-title":"Anti-drug antibodies are associated with diminished drug levels and treatment failure (abstract)","volume":"64","author":"Kosmac","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0370","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/rheumatology\/keu305","article-title":"Anti-adalimumab antibodies in paediatric rheumatology patients: A pilot experience","volume":"53","author":"Murias","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0375","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/annrheumdis-2012-201544","article-title":"Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner","volume":"71","author":"Krieckaert","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0380","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0385","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jbspin.2006.01.007","article-title":"Methotrexate therapy for rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion","volume":"73","author":"Pavy","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0390","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0395","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3899\/jrheum.100930","article-title":"A new approach to clinical care of juvenile idiopathic arthritis: The Juvenile Arthritis Multidimensional Assessment Report","volume":"38","author":"Filocamo","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2015.05.005_bib0400","first-page":"S141","article-title":"The European Spanish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ)","volume":"19","author":"De Inocencio","year":"2001","journal-title":"Clin Exp Rheumatol"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403315002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403315002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:43:43Z","timestamp":1787107423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403315002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1695403315002234"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2015.05.005","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones para el uso de metotrexato en pacientes con artritis idiop\u00e1tica juvenil","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}